This protocol is judged by an institutional critique board, an unbiased group that opinions any medical trials involving people. If a analyze consists of a Program I drug, after the board approves the protocol as moral, the scientists must make an application for an investigational new drug (IND) quantity within the FDA.Although the protocols need